"non small lung cancer" trang 4 - tải miễn phí từ tailieunhanh
Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Osimertinib in advanced EGFRT790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
12    32    1
Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer

Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer
17    18    1
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocytemonocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy
13    18    1
Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively

Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively
10    48    1
Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings

Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings
13    42    1
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using reallife data
11    44    1
Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1- rearranged advanced non-small cell lung cancer (NSCLC) in Canada
13    53    1
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: A retrospective cohort study
14    53    1
Analysis of EGFR gene mutation in patients with non-small cell lung cancer in Hue Central Hospital

Analysis of EGFR gene mutation in patients with non-small cell lung cancer in Hue Central Hospital
5    1    1
Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease

Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease
6    7    1
Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: A case report

Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: A case report
6    1    1
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
8    69    1
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies

Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
10    75    1
Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
10    39    1
The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer

The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
10    53    1
Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study
9    29    1
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study
10    86    1
Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo

Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo
13    69    1
LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p

LncRNA LINC00240 suppresses invasion and migration in non-small cell lung cancer by sponging miR-7-5p
13    43    1
Is prior cancer history a hindrance for non-small cell lung cancer patients to participate in clinical trials

Is prior cancer history a hindrance for non-small cell lung cancer patients to participate in clinical trials
10    1    1